NO20034864L - Preparat for behandling av legemiddelindusert forstoppelse med 15-keto-prostaglandiner - Google Patents

Preparat for behandling av legemiddelindusert forstoppelse med 15-keto-prostaglandiner

Info

Publication number
NO20034864L
NO20034864L NO20034864A NO20034864A NO20034864L NO 20034864 L NO20034864 L NO 20034864L NO 20034864 A NO20034864 A NO 20034864A NO 20034864 A NO20034864 A NO 20034864A NO 20034864 L NO20034864 L NO 20034864L
Authority
NO
Norway
Prior art keywords
prostaglandins
keto
drug
preparation
treatment
Prior art date
Application number
NO20034864A
Other languages
English (en)
Other versions
NO335143B1 (no
NO20034864D0 (no
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23104042&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20034864(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of NO20034864D0 publication Critical patent/NO20034864D0/no
Publication of NO20034864L publication Critical patent/NO20034864L/no
Publication of NO335143B1 publication Critical patent/NO335143B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20034864A 2001-05-02 2003-10-31 Anvendelse av en 15-keto-prostaglandinforbindelse til fremstilling av et farmasøytisk preparat for behandling av legemiddelindusert forstoppelse, hvor den legemiddelinduserte forstoppelsen er opioid eller antikolinergika legemiddelindusert forstoppelse NO335143B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28772001P 2001-05-02 2001-05-02
PCT/JP2002/004223 WO2002089812A1 (en) 2001-05-02 2002-04-26 Composition for treating drug-induced constipation with 15-keto-prostaglandins

Publications (3)

Publication Number Publication Date
NO20034864D0 NO20034864D0 (no) 2003-10-31
NO20034864L true NO20034864L (no) 2003-12-23
NO335143B1 NO335143B1 (no) 2014-09-29

Family

ID=23104042

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034864A NO335143B1 (no) 2001-05-02 2003-10-31 Anvendelse av en 15-keto-prostaglandinforbindelse til fremstilling av et farmasøytisk preparat for behandling av legemiddelindusert forstoppelse, hvor den legemiddelinduserte forstoppelsen er opioid eller antikolinergika legemiddelindusert forstoppelse

Country Status (19)

Country Link
US (1) US6982283B2 (no)
EP (1) EP1392318B1 (no)
JP (1) JP4332353B2 (no)
KR (1) KR100886598B1 (no)
CN (1) CN1522147B (no)
AR (2) AR035237A1 (no)
AT (1) ATE355067T1 (no)
AU (1) AU2002251554B2 (no)
BR (1) BR0209327A (no)
CA (1) CA2444103C (no)
DE (1) DE60218451T2 (no)
DK (1) DK1392318T3 (no)
ES (1) ES2282408T3 (no)
MX (1) MXPA03010019A (no)
NO (1) NO335143B1 (no)
NZ (1) NZ529187A (no)
PT (1) PT1392318E (no)
TW (1) TWI302100B (no)
WO (1) WO2002089812A1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1420794B1 (en) 2001-08-31 2017-12-27 Sucampo AG Prostaglandin analogs as chloride channel openers
TWI331920B (en) 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
US7732487B2 (en) 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
EP1562604B1 (en) * 2002-10-23 2012-01-04 Sucampo AG Prostaglandin compounds for the treatment of obesity
MXPA05006981A (es) 2002-12-27 2005-12-14 Sucampo Ag Derivados de prostaglandinas para el tratamiento de la molestia abdominal.
TWI387454B (zh) * 2004-09-02 2013-03-01 Sucampo Ag 治療胃腸道疾病之方法及組成物
ES2714198T3 (es) * 2005-03-07 2019-05-27 Univ Chicago Uso de antagonistas opioideos para atenuar la proliferación y la migración de células endoteliales
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8524731B2 (en) * 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
WO2006109881A1 (en) * 2005-04-12 2006-10-19 Sucampo Ag Combined use of prostaglandin compound and proton pump inhibitor for the treatment of gastrointestinal disorders
US20090030072A1 (en) * 2007-07-03 2009-01-29 Sucampo Ag Pharmaceutical combination of opioid and prostaglandin compound
US20090082442A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched lubiprostone
US9044510B2 (en) * 2007-11-01 2015-06-02 Washington University Compositions and methods for treating pruritus
US9084815B2 (en) * 2009-09-16 2015-07-21 Sucampo Ag Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor
US8957024B2 (en) 2011-07-27 2015-02-17 Washington University Composition and methods for reducing opioid-induced pruritus
KR20140052389A (ko) 2012-10-24 2014-05-07 주식회사 아리바이오 해양 심층수 또는 염지하수로부터 제조된 고경도의 미네랄 워터를 포함하는 변비 예방, 개선 또는 치료용 조성물
US20140116916A1 (en) 2012-10-31 2014-05-01 2294719 Ontario Limited Therapy for Constipation
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space
CN105777601A (zh) * 2014-12-26 2016-07-20 中国人民解放军第二军医大学 一种前列地尔衍生物及其药物制剂
JP2019513355A (ja) * 2016-03-29 2019-05-30 コロナリーコンセプツ エルエルシー 便秘症を処置するための製剤
WO2018065826A1 (en) * 2016-10-06 2018-04-12 Sucampo Ag Multilayer beads for pharmaceutical use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1581886A (en) * 1977-05-26 1980-12-31 May & Baker Ltd Prostanol derivatives
US5166174A (en) 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
CA1322749C (en) 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
US5221763A (en) 1987-04-30 1993-06-22 R-Tech Ueno, Ltd. Prostaglandins of the F series
US5317032A (en) 1987-10-02 1994-05-31 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Prostaglandin cathartic
ATE78465T1 (de) * 1987-10-02 1992-08-15 Ueno Seiyaku Oyo Kenkyujo Kk Kathartica.
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
TW224942B (no) 1990-04-04 1994-06-11 Adka Ueno Kk
EP0455448B1 (en) * 1990-05-01 1998-12-09 R-Tech Ueno Ltd. Treatment of pancreatic disease with 15-keto-prostaglandin E compounds
CA2150287C (en) 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
EP0857718B1 (en) 1996-06-10 2002-08-14 Sucampo AG Endothelin antagonist
US6414016B1 (en) * 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
PT1389116E (pt) * 2001-05-18 2008-04-11 Sucampo Ag Composição de indução catártica

Also Published As

Publication number Publication date
BR0209327A (pt) 2004-07-20
MXPA03010019A (es) 2004-02-12
DK1392318T3 (da) 2007-06-25
US20030073746A1 (en) 2003-04-17
PT1392318E (pt) 2007-05-31
CN1522147B (zh) 2010-05-12
KR100886598B1 (ko) 2009-03-05
NO335143B1 (no) 2014-09-29
AU2002251554B2 (en) 2007-05-24
KR20040008168A (ko) 2004-01-28
AR100696A2 (es) 2016-10-26
ATE355067T1 (de) 2006-03-15
CA2444103A1 (en) 2002-11-14
NO20034864D0 (no) 2003-10-31
EP1392318B1 (en) 2007-02-28
TWI302100B (en) 2008-10-21
DE60218451T2 (de) 2007-11-08
CN1522147A (zh) 2004-08-18
ES2282408T3 (es) 2007-10-16
NZ529187A (en) 2005-10-28
CA2444103C (en) 2010-06-08
JP2004527567A (ja) 2004-09-09
US6982283B2 (en) 2006-01-03
EP1392318A1 (en) 2004-03-03
WO2002089812A1 (en) 2002-11-14
DE60218451D1 (de) 2007-04-12
AR035237A1 (es) 2004-05-05
JP4332353B2 (ja) 2009-09-16

Similar Documents

Publication Publication Date Title
NO20034864D0 (no) Preparat for behandling av legemiddelindusert forstoppelse med 15-keto-prostaglandiner
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20050136D0 (no) Fremgangsmate for fremstilling av mikropartikler
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
NO20043000L (no) Et preparat for behandling av nevrocerebrovaskulaere sykdommer
NO20040097L (no) Kombinasjoner for behandling av inflammatoriske forstyrrelser
NO20042140L (no) Terapeutiske quionolonforbindelser med 5-HT anatagonistiske egenskaper
NO20031443L (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
NO20040253L (no) Fremgangsmater for behandling av leverfibroser
NO20040027L (no) Fremgangsmate for fremstillingen av escitalopram
NO20040278L (no) Fremgangsmate for fremstilling av perindopril
NO20030163L (no) Fremgangsmate for fremstilling av olefiner
NO20032731D0 (no) Fremgangsmåte for fremstilling av sulfonamid-substituerte imidazotriazinoner
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
FI20011889A (fi) Menetelmä ksylitolin valmistamiseksi
NO20034123L (no) Fremgangsmåte for behandling av brennstoff
NO20035538D0 (no) Fremgangsmåte for fremstilling av zaleplon
NO20042640L (no) Fremgangsmate for fremstilling av ekinocandinderivater
NO20026155L (no) Fremgangsmåte for fremstilling av lavere olefiner
NO20035586L (no) Fremgangsmate for fremstilling av cykloheksanol-derivater
NO20030515L (no) Fremgangsmåte for fremstilling av dinapsolin
NO20030717L (no) Forbindelser for behandling av avhengighetsforstyrrelser
NO20044332L (no) Forbedret fremgangsmate for fremstilling av nevirapine
NO20042202L (no) Fremgangsmate for fremstilling av asymmetriske karotenoider
NO20033290L (no) Pyrrolderivater for behandling av cytokinformidlede sykdommer

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees